Migraine Prevention
Showing 1 - 25 of >10,000
Migraine Disorders Trial in Kafr Ash Shaykh (Lacosamide 100 mg)
Recruiting
- Migraine Disorders
- Lacosamide 100 mg
-
Kafr Ash Shaykh, EgyptKafr Elsheikh University Hospital
Apr 30, 2023
Study Assessing Safety and Efficacy of Nerivio for Migraine
Recruiting
- Migraine
- Nerivio
-
Bridgewater, New JerseyTheranica Inc USA
Jul 10, 2023
DaxibotulinumtoxinA for Migraine Prevention
Recruiting
- Migraine Disorders
-
Stamford, ConnecticutNew England Institute For Clinical Research
Nov 30, 2023
Migraine Trial in Copenhagen (Calcitonin Gene-Related Peptide, Erenumab)
Recruiting
- Migraine
- Calcitonin Gene-Related Peptide
- Erenumab
-
Copenhagen, Glostrup, DenmarkDanish Headache Center
Oct 21, 2022
Migraine Headache Trial in Sherbrooke (Nutritional Ketogenic Supplement, Isocaloric supplement)
Completed
- Migraine Headache
- Nutritional Ketogenic Supplement
- Isocaloric placebo supplement
-
Sherbrooke, Quebec, CanadaDiex Research Sherbrooke Inc.
Dec 20, 2022
Chronic Migraine, Headache Trial in Stamford (Daxibotulinumtonix A)
Recruiting
- Chronic Migraine, Headache
- Daxibotulinumtonix A
-
Stamford, ConnecticutNew England Institute for Clinical Research
Nov 9, 2023
Migraine, Episodic Migraine, Headache Trial in New York (ReMMi-D Digital Therapeutic)
Recruiting
- Migraine
- +3 more
- ReMMi-D Digital Therapeutic
-
New York, New YorkClick Therapeutics
May 10, 2023
Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)
Recruiting
- Migraine
- +3 more
- Click Digital Therapeutic
-
New York, New YorkClick Therapeutics
Aug 15, 2023
Chronic Migraine Trial (Dysport®, Placebo)
Not yet recruiting
- Chronic Migraine
- Dysport®
- Placebo
- (no location specified)
Sep 14, 2023
Episodic Migraine Trial (Dysport®, Placebo)
Not yet recruiting
- Episodic Migraine
- Dysport®
- Placebo
- (no location specified)
Sep 14, 2023
Migraine Trial in Estonia, Norway (Candesartan Oral Tablet 8 mg, Candesartan Oral Tablet 16 mg, Placebo oral tablet)
Recruiting
- Migraine
- Candesartan Oral Tablet 8 mg
- +2 more
-
Tartu, Estonia
- +9 more
Apr 28, 2022
Migraine, Classic Trial in Wuhan (Transcutaneous Supraorbital Nerve Stimulator, Topiramate 25Mg Tab)
Recruiting
- Migraine, Classic
- Transcutaneous Supraorbital Nerve Stimulator
- Topiramate 25Mg Tab
-
Wuhan, Hubei, ChinaWensheng Qu
Aug 23, 2022
Migraine, Omega-3 Polyunsaturated Fatty Acids Trial in Taichung (Omega-3 polyunsaturated fatty acids, omega-6 PUFAs)
Completed
- Migraine
- Omega-3 Polyunsaturated Fatty Acids
- Omega-3 polyunsaturated fatty acids
- omega-6 PUFAs
-
Taichung, TaiwanKuang Tien General Hospital
Jun 22, 2022
Migraine Trial in Lørenskog, Trondheim (Cerebri biofeedback, Cerebri headache diary)
Not yet recruiting
- Migraine
- Cerebri biofeedback
- Cerebri headache diary
-
Lørenskog, Viken, Norway
- +1 more
Nov 7, 2022
Migraine Trial in United States (Nerivio active device, Nerivio sham device)
Completed
- Migraine
- Nerivio active device
- Nerivio sham device
-
Phoenix, Arizona
- +15 more
Oct 21, 2022
Migraine Disorders, Headache Disorders Trial in Memphis (SPN-538, Placebo)
Recruiting
- Migraine Disorders
- Headache Disorders
- SPN-538
- Placebo
-
Memphis, TennesseeCNS Healthcare
Nov 29, 2021
Disease Activity When Ubrogepant Tablets Are Combined With
Recruiting
- Migraine
-
Bronx, New YorkMontefiore/Albert Einstein
Jan 9, 2023
Chronic Migraine, Chronic Migraine, Headache, Chronic Migraine Without Aura Trial in United States (TNX-1900, Placebo Nasal
Recruiting
- Chronic Migraine
- +3 more
- TNX-1900
- Placebo Nasal Spray
-
Lemon Grove, California
- +23 more
Jan 10, 2023